Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation

International Immunopharmacology

Volumn 15, Issue 2, 2013, Pages 316-324

  Yao, Xiangyang ^a   Li, Guilan ^b   Bai, Qin ^c   Xu, Hui ^a   Lü, Chaotian ^a  

^a Bengbu College   (China)

^b SHANXI AGRICULTURAL UNIVERSITY   (China)

^c Anhui Fukang Pharmaceutical Co Ltd   (China)

Author keywords

Akt; MAPK; NF B; RAW264.7 cells; TAK1; Taraxerol

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE B; TARAXEROL; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

EID: 84872930365     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.12.032     Document Type: Article

References (46)

1. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511
2. H. Sakurai Targeting of TAK1 in inflammatory disorders and cancer Trends Pharmacol Sci 33 2012 522 530
3. J.H. Shim, C. Xiao, A.E. Paschal, S.T. Bailey, P. Rao, and M.S. Hayden TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo Genes Dev 19 2005 2668 2681
4. M. Landstrom The TAK1-TRAF6 signalling pathway Int J Biochem Cell Biol 42 2010 585 589
5. B. Skaug, X. Jiang, and Z.J. Chen The role of ubiquitin in NF-κB regulatory pathways Annu Rev Biochem 78 2009 769 796
6. N. Rajapakse, M.-M. Kim, E. Mendis, and S.-K. Kim Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-κB signaling Immunology 123 2008 348 357
7. L. Chang, and M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40
8. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nat Cell Biol 4 2002 E131 E136
9. M. Ojaniemi, V. Glumoff, K. Harju, M. Liljeroos, K. Vuori, and M. Hallman Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages Eur J Immunol 33 2003 597 605
10. S.J. Park, S.C. Lee, S.H. Hong, and H.M. Kim Degradation of IκBα in activated RAW264.7 cells is blocked by the phosphatidylinositol 3-kinase inhibitor LY294002 Cell Biol Toxicol 18 2002 121 130
11. Y.H. Kim, K.-H. Choi, J.-W. Park, and T.K. Kwon LY294002 inhibits LPS-induced NO production through a inhibition of NF-κB activation: independent mechanism of phosphatidylinositol 3-kinase Immunol Lett 99 2005 45 50
12. C.-C. Kuo, W.-T. Lin, C.-M. Liang, and S.-M. Liang Class I and III phosphatidylinositol 3′-kinase play distinct roles in TLR signaling pathway J Immunol 176 2006 5943 5949
13. M. Ruse, and U. Knaus New players in TLR-mediated innate immunity Immunol Res 34 2006 33 48
14. T. Fukao, and S. Koyasu PI3K and negative regulation of TLR signaling Trends Immunol 24 2003 358 363
15. K.N. Sangeetha, S. Sujatha, V.S. Muthusamy, S. Anand, N. Nithya, and D. Velmurugan 3beta-Taraxerol of Mangifera indica, a PI3K dependent dual activator of glucose transport and glycogen synthesis in 3T3-L1 adipocytes Biochim Biophys Acta 1800 2010 359 366
16. C.C. Tsao, Y.C. Shen, C.R. Su, C.Y. Li, M.J. Liou, and N.X. Dung New diterpenoids and the bioactivity of Erythrophleum fordii Bioorg Med Chem 16 2008 9867 9870
17. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 2005 749 759
18. J. Shan, J. Fu, Z. Zhao, X. Kong, H. Huang, and L. Luo Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-[kappa]B and JNK/AP-1 activation Int Immunopharmacol 9 2009 1042 1048
19. C. Wang, L. Deng, M. Hong, G.R. Akkaraju, J. Inoue, and Z.J. Chen TAK1 is a ubiquitin-dependent kinase of MKK and IKK Nature 412 2001 346 351
20. Y. Fan, Y. Shi, S. Liu, R. Mao, L. An, and Y. Zhao Lys(48)-linked TAK1 polyubiquitination at lysine-72 downregulates TNFalpha-induced NF-kappaB activation via mediating TAK1 degradation Cell Signal 24 2012 1381 1389
21. Y. Fan, Y. Yu, Y. Shi, W. Sun, M. Xie, and N. Ge Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation J Biol Chem 285 2010 5347 5360
22. J.S. Shin, S.J. Park, S. Ryu, H.B. Kang, T.W. Kim, and J.H. Choi Potent anti-inflammatory effect of a novel furan-2,5-dione derivative, BPD, mediated by dual suppression of COX-2 activity and LPS-induced inflammatory gene expression via NF-kappaB inactivation Br J Pharmacol 165 2012 1926 1940
23. Y.J. Kim, H.C. Kim, H. Ko, E.C. Amor, J.W. Lee, and H.O. Yang Stercurensin inhibits nuclear factor-kappaB-dependent inflammatory signals through attenuation of TAK1-TAB1 complex formation J Cell Biochem 112 2011 548 558
24. R. Scholz, C.L. Sidler, R.F. Thali, N. Winssinger, P.C. Cheung, and D. Neumann Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process J Biol Chem 285 2010 25753 25766
25. K. Kishimoto, K. Matsumoto, and J. Ninomiya-Tsuji TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop J Biol Chem 275 2000 7359 7364
26. A. Adhikari, M. Xu, and Z.J. Chen Ubiquitin-mediated activation of TAK1 and IKK Oncogene 26 2007 3214 3226
27. V.G. Bhoj, and Z.J. Chen Ubiquitylation in innate and adaptive immunity Nature 458 2009 430 437
28. L. Liang, Y. Fan, J. Cheng, D. Cheng, Y. Zhao, and B. Cao TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation Cell Signal 25 2013 247 254
29. N. Ahmed, M. Zeng, I. Sinha, L. Polin, W.Z. Wei, and C. Rathinam The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation Nat Immunol 12 2011 1176 1183
30. K. Newton, M.L. Matsumoto, I.E. Wertz, D.S. Kirkpatrick, J.R. Lill, and J. Tan Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies Cell 134 2008 668 678
31. E.W. Harhaj, and V.M. Dixit Deubiquitinases in the regulation of NF-[kappa]B signaling Cell Res 21 2011 22 39
32. K. Iwai Diverse ubiquitin signaling in NF-κB activation Trends Cell Biol 22 2012 355 364
33. M. Hanada, J. Ninomiya-Tsuji, K. Komaki, M. Ohnishi, K. Katsura, and R. Kanamaru Regulation of the TAK1 signaling pathway by protein phosphatase 2C J Biol Chem 276 2001 5753 5759
34. T. Kajino, H. Ren, S. Iemura, T. Natsume, B. Stefansson, and D.L. Brautigan Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway J Biol Chem 281 2006 39891 39896
35. S.I. Kim, J.H. Kwak, L. Wang, and M.E. Choi Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells J Biol Chem 283 2008 10753 10763
36. K. Tsukamoto, K. Hazeki, M. Hoshi, K. Nigorikawa, N. Inoue, and T. Sasaki Critical roles of the p110β subtype of phosphoinositide 3-kinase in lipopolysaccharide-induced Akt activation and negative regulation of nitrite production in RAW 264.7 cells J Immunol 180 2008 2054 2061
37. M.H.W. Laird, S.H. Rhee, D.J. Perkins, A.E. Medvedev, W. Piao, and M.J. Fenton TLR4/MyD88/PI3K interactions regulate TLR4 signaling J Leukocyte Biol 85 2009 966 977
38. J.P. Luyendyk, G.A. Schabbauer, M. Tencati, T. Holscher, R. Pawlinski, and N. Mackman Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages J Immunol 180 2008 4218 4226
39. C.P. Bauerfeld, R. Rastogi, G. Pirockinaite, I. Lee, M. Huttemann, and B. Monks TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages J Immunol 188 2012 2847 2857
40. W.F. Chiou, M.J. Don, J.F. Liao, and B.L. Wei Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IkappaB signaling pathways Eur J Pharmacol 650 2011 102 109
41. C.Q. Xu, B.J. Liu, J.F. Wu, Y.C. Xu, X.H. Duan, and Y.X. Cao Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway Eur J Pharmacol 642 2010 146 153
42. Y.H. Kuan, F.M. Huang, Y.C. Li, and Y.C. Chang Proinflammatory activation of macrophages by bisphenol A-glycidyl-methacrylate involved NFkappaB activation via PI3K/Akt pathway Food Chem Toxicol 50 2012 4003 4009
43. S. Qi, Y. Xin, Y. Guo, Y. Diao, X. Kou, and L. Luo Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways Int Immunopharmacol 12 2012 278 287
44. V.R. Yadav, S. Prasad, B. Sung, R. Kannappan, and B.B. Aggarwal Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer Toxins 2 2010 2428 2466
45. J.-L. Ríos Effects of triterpenes on the immune system J Ethnopharmacol 128 2010 1 14
46. P. Codogno, M. Mehrpour, and T. Proikas-Cezanne Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol 13 2012 7 12